FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
+27.54%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$435M
AUM Growth
+$435M
(+15%)
Cap. Flow
-$45.3M
Cap. Flow
% of AUM
-10.4%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
10x Genomics
TXG
|
$45.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
10x Genomics
TXG
$1.74B
| $408M | 93.76% | 2,253,528 -250,000 | -10% | -$45.3M |
|
2
Novavax
NVAX
$1.21B
| $12.2M | 2.81% | 67,373 | – | – |
|
|
EPZM
3
DELISTED
Epizyme, Inc
EPZM
| $8.71M | 2% | 1,000,002 | – | – |
|
|
XLRN
4
DELISTED
Acceleron Pharma Inc.
XLRN
| $6.22M | 1.43% | 45,884 | – | – |
|